相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Childhood cancer in India
Shuvadeep Ganguly et al.
CANCER EPIDEMIOLOGY (2021)
Treatment abandonment in children with cancer: Does a sex difference exist? A systematic review and meta-analysis of evidence from low- and middle-income countries
Anna Palagyi et al.
INTERNATIONAL JOURNAL OF CANCER (2021)
IAP Chemotherapy Regimen Is a Viable and Cost-effective Option in Children and Adolescents With Osteosarcoma: A Comparative Analysis With MAP Regimen on Toxicity and Survival
Priyanka Verma et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2021)
Efficacy and safety of oral metronomic etoposide in adult patients with metastatic osteosarcoma
Audrey Perret et al.
CANCER MEDICINE (2021)
Bone sarcomas: ESMO-EURACAN-GENTURIS-ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up
S. J. Strauss et al.
ANNALS OF ONCOLOGY (2021)
Results of API-AI based regimen in osteosarcoma adult patients included in the French OS2006/Sarcome-09 study
Sophie Piperno-Neumann et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Pharmacogenomics and Pharmacogenetics in Osteosarcoma: Translational Studies and Clinical Impact
Claudia Maria Hattinger et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Economic perspective of cancer treatment in India
Aparna Natarajan et al.
MEDICAL ONCOLOGY (2020)
Delivery of Services to Childhood Cancer Survivors in India: A National Survey
Vatsna Rathore et al.
INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY (2020)
Decreasing Cost and Decreasing Length of Stay After Implementation of Updated High-Dose Methotrexate Discharge Criteria
Adam F. Binder et al.
JCO ONCOLOGY PRACTICE (2020)
Factors affecting compliance to hospital visit among clubfoot patients: A cross-sectional study from a tertiary referral clubfoot clinic in the developing country
Rishi R. Poudel et al.
JOURNAL OF ORTHOPAEDIC SURGERY (2019)
Osteosarcoma journey over two decades in India: Small steps, big changes
Jyoti Bajpai et al.
PEDIATRIC BLOOD & CANCER (2019)
Viable and necrotic tumor assessment from whole slide images of osteosarcoma using machine-learning and deep-learning models
Harish Arunachalam et al.
PLOS ONE (2019)
A prospective study on urine alkalization with an oral regimen consisting of sodium bicarbonate and acetazolamide in patients receiving high-dose methotrexate
Daniel R. Reed et al.
CANCER MANAGEMENT AND RESEARCH (2019)
Oral Methods of Urinary Alkalinization for High-dose Methotrexate Administration: Alternatives to Intravenous Sodium Bicarbonate During a Critical Drug Shortage
Rachel Visage et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2019)
Medical Oncology in India: Workload, Infrastructure, and Delivery of Care
Manju Sengar et al.
INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY (2019)
Current questions in bone sarcomas
Sandra J. Strauss et al.
CURRENT OPINION IN ONCOLOGY (2018)
Methotrexate free chemotherapy and limb salvage surgery for paediatric osteosarcoma in India
Reghu Kesavapillai Sukumaran et al.
INDIAN JOURNAL OF ORTHOPAEDICS (2018)
Reconstructing diaphyseal tumors using radiated (50 Gy) autogenous tumor bone graft
Ajay Puri et al.
JOURNAL OF SURGICAL ONCOLOGY (2018)
Economic burden of cancer in India: Evidence from cross-sectional nationally representative household survey, 2014
Sunil Rajpal et al.
PLOS ONE (2018)
Results of a Randomized, Prospective Clinical Trial Evaluating Metronomic Chemotherapy in Nonmetastatic Patients With High-Grade, Operable Osteosarcomas of the Extremities: A Report From the Latin American Group of Osteosarcoma Treatment
Andreza A. Senerchia et al.
CANCER (2017)
Outcomes in non-metastatic treatment naive extremity osteosarcoma patients treated with a novel non-high dosemethotrexate-based, dose-dense combination chemotherapy regimen 'OGS-12'
Jyoti Bajpai et al.
EUROPEAN JOURNAL OF CANCER (2017)
Histopathologic review of 400 biopsies and resection specimens of trunk and extremity-based soft tissue tumors
R. Badanale et al.
INDIAN JOURNAL OF CANCER (2017)
Factors associated with local recurrence in operated osteosarcomas: A retrospective evaluation of 95 cases from a tertiary care center in a resource challenged environment
Rishi R. Poudel et al.
JOURNAL OF SURGICAL ONCOLOGY (2017)
Histopathologic review of 400 biopsies and resection specimens of trunk and extremity-based soft tissue tumors
R. Badanale et al.
INDIAN JOURNAL OF CANCER (2017)
Metronomic Chemotherapy vs Best Supportive Care in Progressive Pediatric Solid Malignant Tumors A Randomized Clinical Trial
Raja Pramanik et al.
JAMA ONCOLOGY (2017)
Financial burden faced by families due to out-of-pocket expenses during the treatment of their cancer children: An Indian perspective
Latha M. Sneha et al.
INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY (2017)
Chemotherapy in Nonmetastatic Osteosarcoma: Recent Advances and Implications for Developing Countries
Sameer Rastogi et al.
JOURNAL OF GLOBAL ONCOLOGY (2017)
Cardioprotection and Second Malignant Neoplasms Associated With Dexrazoxane in Children Receiving Anthracycline Chemotherapy: A Systematic Review and Meta-Analysis
Furqan Shaikh et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Intensified Chemotherapy With Dexrazoxane Cardioprotection in Newly Diagnosed Nonmetastatic Osteosarcoma: A Report From the Children's Oncology Group
Cindy L. Schwartz et al.
PEDIATRIC BLOOD & CANCER (2016)
Cardioprotection and Second Malignant Neoplasms Associated With Dexrazoxane in Children Receiving Anthracycline Chemotherapy: A Systematic Review and Meta-Analysis
Furqan Shaikh et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial
Neyssa M. Marina et al.
LANCET ONCOLOGY (2016)
Preventing and Managing Toxicities of High-Dose Methotrexate
Scott C. Howard et al.
ONCOLOGIST (2016)
Determinants of Treatment Abandonment in Childhood Cancer: Results from a Global Survey
Paola Friedrich et al.
PLOS ONE (2016)
Chemotherapy for Bone Sarcoma in Adults
Michael J. Wagner et al.
JOURNAL OF ONCOLOGY PRACTICE (2016)
Effect of Unplanned Therapy on the Prognosis of Patients with Extremity Osteosarcoma
Bing Wang et al.
Scientific Reports (2016)
Improving Cancer Treatment via Mathematical Modeling: Surmounting the Challenges Is Worth the Effort
Franziska Michor et al.
CELL (2015)
Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial
Stefan S. Bielack et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Developing a prognostic model for patients with localized osteosarcoma treated with uniform chemotherapy protocol without high dose methotrexate: A single-center experience of 237 patients
Vijayamurugan Nataraj et al.
JOURNAL OF SURGICAL ONCOLOGY (2015)
Serum Creatinine Versus Plasma Methotrexate Levels to Predict Toxicities in Children Receiving High-dose Methotrexate
Priya Tiwari et al.
PEDIATRIC HEMATOLOGY AND ONCOLOGY (2015)
Dexrazoxane Exposure and Risk of Secondary Acute Myeloid Leukemia in Pediatric Oncology Patients
Alix E. Seif et al.
PEDIATRIC BLOOD & CANCER (2015)
Extended Duration of Prehydration Does Not Prevent Nephrotoxicity or Delayed Drug Elimination in High-Dose Methotrexate Infusions: A Prospectively Randomized Cross-Over Study
Torben Stamm Mikkelsen et al.
PEDIATRIC BLOOD & CANCER (2014)
A Phase II Trial of a Multi-Agent Oral Antiangiogenic (Metronomic) Regimen in Children With Recurrent or Progressive Cancer
Nathan J. Robison et al.
PEDIATRIC BLOOD & CANCER (2014)
Pediatric Sarcoma in Central America Outcomes, Challenges, and Plans for Improvement
Paola Friedrich et al.
CANCER (2013)
Chemotherapy Compliance in Patients With Osteosarcoma
Jyoti Bajpai et al.
PEDIATRIC BLOOD & CANCER (2013)
Improving the prognosis of pediatric hodgkin lymphoma in developing countries: A moroccan society of pediatric hematology and oncology study
Laila Hessissen et al.
PEDIATRIC BLOOD & CANCER (2013)
Fifteen Years' Experience of the Brazilian Osteosarcoma Treatment Group (BOTG): A Contribution from an Emerging Country
Antonio Sergio Petrilli et al.
JOURNAL OF ADOLESCENT AND YOUNG ADULT ONCOLOGY (2013)
Proximal humeral reconstruction using nail cement spacer in primary and metastatic tumours of proximal humerus
Zile Singh Kundu et al.
STRATEGIES IN TRAUMA AND LIMB RECONSTRUCTION (2013)
Unplanned Excision of Soft Tissue Sarcoma Results in Increased Rates of Local Recurrence Despite Full Further Oncological Treatment
Y. A. Qureshi et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
High dose methotrexate chemotherapy: pharmacokinetics, folate and toxicity in osteosarcoma patients
Laila Holmboe et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Outcome for adolescent and young adult patients with osteosarcoma
Katherine A. Janeway et al.
CANCER (2012)
Results of the Scandinavian Sarcoma Group XIV protocol for classical osteosarcoma 63 patients with a minimum follow-up of 4 years
Sigbjorn Smeland et al.
ACTA ORTHOPAEDICA (2011)
Twenty Years of Follow-Up of Survivors of Childhood Osteosarcoma
Rajaram Nagarajan et al.
CANCER (2011)
Frontline Treatment of Localized Osteosarcoma Without Methotrexate Results of the St. Jude Children's Research Hospital OS99 Trial
Najat C. Daw et al.
CANCER (2011)
Intensive induction chemotherapy without methotrexate in adult patients with localized osteosarcoma: results of the Institut Gustave-Roussy phase II trial
H. Assi et al.
Current Oncology (2011)
Chemotherapeutic adjuvant treatment for osteosarcoma: Where do we stand?
Jakob K. Anninga et al.
EUROPEAN JOURNAL OF CANCER (2011)
Prediction of Chemotherapy Response by PET-CT in Osteosarcoma: Correlation With Histologic Necrosis
Jyoti Bajpai et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2011)
Role of MRI in osteosarcoma for evaluation and prediction of chemotherapy response: correlation with histological necrosis
Jyoti Bajpai et al.
PEDIATRIC RADIOLOGY (2011)
Prognostic markers in osteosarcoma
Sameer Bakhshi et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2010)
Noninvasive Imaging Surrogate of Angiogenesis in Osteosarcoma
Jyoti Bajpai et al.
PEDIATRIC BLOOD & CANCER (2010)
Advances in individual prediction of methotrexate toxicity: a review
Kjeld Schmiegelow
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Effect of Time to Resumption of Chemotherapy After Definitive Surgery on Prognosis for Non-Metastatic Osteosarcoma
Hamayun Imran et al.
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME (2009)
Sex- and Age-Related Chemotherapy Toxicity in Patients with Non-Metastatic Osteosarcoma
S. Ferrari et al.
JOURNAL OF CHEMOTHERAPY (2009)
High-dose methotrexate in osteosarcoma: Let the questions surcease - Time for final acceptance
Norman Jaffe et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Osteosarcoma: The addition of muramyl tripeptide to chemotherapy improves overall survival - A report from the Children's Oncology Group
Paul A. Meyers et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
The problem of treatment abandonment in children from developing countries with cancer
Ramandeep Singh Arora et al.
PEDIATRIC BLOOD & CANCER (2007)
Limb salvage surgery for osteosarcoma - Effective low-cost treatment
Manish Agarwal et al.
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH (2007)
Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy: A randomized phase III trial of the European Osteosarcoma Intergroup
Ian J. Lewis et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
A phase II study of cisplatin, ifosfamide and epirubicin combination chemotherapy in adults with nonmetastatic and extremity osteosarcomas
Mert Basaran et al.
ONCOLOGY (2007)
Understanding and managing methotrexate nephrotoxicity
Brigitte C. Widemann et al.
ONCOLOGIST (2006)
Results of the Brazilian Osteosarcoma Treatment Group studies III and IV:: Prognostic factors and impact on survival
AS Petrilli et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Treatment of osteosarcoma at first recurrence after contemporary therapy - The Memorial Sloan-Kettering Cancer Center Experience
AJ Chou et al.
CANCER (2005)
Treatment and outcome of recurrent osteosarcoma: Experience at Rizzoli in 235 patients initially treated with neoadjuvant chemotherapy
G Bacci et al.
ACTA ONCOLOGICA (2005)
Methotrexate levels and outcome in osteosarcoma
S Zelcer et al.
PEDIATRIC BLOOD & CANCER (2005)
Osteosarcoma: A randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate
PA Meyers et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
High dose methotrexate in adult patients with osteosarcoma: Clinical and pharmacokinetic results
A Comandone et al.
ACTA ONCOLOGICA (2005)
High-dose methotrexate pharmacokinetics and outcome of children and young adults with osteosarcoma
KR Crews et al.
CANCER (2004)
Methotrexate pharmacokinetics and survival in osteosarcoma
I Aquerreta et al.
PEDIATRIC BLOOD & CANCER (2004)
Outcome after local recurrence of osteosarcoma - The St. Jude Children's Research Hospital experience (1970-2000)
C Rodriguez-Galindo et al.
CANCER (2004)
Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric oncology group study POG-8651
AM Goorin et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Dose-intense ifosfamide/doxorubicin/cisplatin based chemotherapy for osteosarcoma in adults
SJ Patel et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2002)
Refusal, non-compliance, and abandonment of treatment in children and adolescents with cancer - A report of the SIOP Working Committee on Phychosocial Issues in Pediatric Oncology
JJ Spinetta et al.
MEDICAL AND PEDIATRIC ONCOLOGY (2002)
Carboplatin/ifosfamide window therapy for osteosarcoma: Results of the St Jude Children's Research Hospital OS-91 trial
WH Meyer et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
分享论文
